Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker MIST
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 13, 2026 | MIST Milestone Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 28, 2026 | MIST Milestone Pharmaceuticals Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Sep 3, 2026 | MIST Milestone Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 12, 2026 | MIST Milestone Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 15, 2026 | MIST Milestone Pharmaceuticals Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 15, 2026 | MIST Milestone Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 13, 2026 | MIST Milestone Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 20, 2026 | MIST Milestone Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 26, 2026 | MIST Milestone Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 13, 2026 | MIST Milestone Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 6, 2026 | MIST Milestone Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 15, 2025 | MIST Milestone Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 15, 2025 | MIST Milestone Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2025 | MIST Milestone Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 12, 2025 | MIST Milestone Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 14, 2025 | MIST Milestone Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 14, 2025 | MIST Milestone Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jul 11, 2025 | MIST Milestone Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 11, 2025 | MIST Milestone Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 16, 2025 | MIST Milestone Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 12, 2025 | MIST Milestone Pharmaceuticals Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 12, 2025 | MIST Milestone Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 14, 2025 | MIST Milestone Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 28, 2025 | MIST Milestone Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 19, 2025 | MIST Milestone Pharmaceuticals Inc. | 5.08 Shareholder Director Nominations | 8-K | 8-K ↗ |
| Mar 18, 2025 | MIST Milestone Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 18, 2025 | MIST Milestone Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 13, 2025 | MIST Milestone Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 25, 2025 | MIST Milestone Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2024 | MIST Milestone Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
30 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:35 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances